We describe the isolation and characterization of a new Lassa virus strain imported into Germany by a traveler who had visited Ghana, Côte D'Ivoire, and Burkina Faso. This strain, designated "AV," originated from a region in West Africa where Lassa fever has not been reported. Viral S RNA isolated from the patient's serum was amplified and sequenced. A long-range reverse transcription polymerase chain reaction allowed amplification of the full-length (3.4 kb) S RNA. The coding sequences of strain AV differed from those of all known Lassa prototype strains (Josiah, Nigeria, and LP) by approximately 20%, mainly at third codon positions. Phylogenetically, strain AV appears to be most closely related to strain Josiah from Sierra Leone. Lassa viruses comprise a group of genetically highly diverse strains, which has implications for vaccine development. The new method for full-length S RNA amplification may facilitate identification and molecular analysis of new arenaviruses or arenavirus strains. Figure 1 . Map of West Africa and travel history of the patient before the onset of febrile illness (day 0). Countries in which Lassa fever is endemic (1) (2) (3) (4) are underlined.
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differences. Sequence analysis of the full-length S RNA of a large number of isolates has been complicated by technical problems such as the necessity to produce enough virus in cell culture for direct cloning (15, 16) or localization of conserved regions within the S RNA for polymerase chain reaction (PCR) primers (18) .
We report the isolation and sequence characterization of a new Lassa virus strain from a traveler who imported the virus into Germany. This novel strain originates from an area of West Africa where Lassa fever has not yet been reported. To facilitate molecular analysis of new Lassa virus isolates, a long-range reverse transcription (RT)-PCR was established. The primers bind to highly conserved RNA termini and allow amplification of full-length S RNA directly from serum.
Methods

The Patient
A 23-year-old German woman became ill with fever and flulike symptoms after traveling through three West African countries (Figure 1 ). In Abidjan, Côte D'Ivoire, she visited the outpatient department of Centre Hospitalier Universitaire de Cocody, where her illness was diagnosed as malaria. She returned to Germany on day 6 of illness and was hospitalized at the Diakonie Hospital at Schwäbisch Hall. After the diagnoses of malaria and bacterial infection were ruled out, the patient was transferred on day 9 of illness to the department of tropical diseases at the Missionsärztliche Klinik in Würzburg, where she was noted to have fever, pharyngitis, diarrhea, and pleural effusion. Lassa fever was suspected, and serum was sent to the BernhardNocht-Institut, Hamburg, where Lassa virus infection was diagnosed by PCR and virus isolation. Despite immediate ribavirin treatment and intensive care, the patient's clinical condition deteriorated, and she died on day 14 of illness with hemorrhage, organ failure, and encephalopathy (19) .
Virus Isolation and Detection by Immunofluorescence and Immunoblot
In the biosafety level 4 facility, Vero cells grown in 10 mL of Leibowitz medium were injected with 1 mL, 0.1 mL, 0.01 mL, and 0.001 mL of serum. The cell culture was examined daily by immunofluorescence for Lassa virus infection as well as morphologic changes. Cells were harvested, spread onto immunofluorescence slides, air-dried, and acetone-fixed. Immunofluorescence was performed by using Lassa virus NPspecific monoclonal antibody L2F1 (20) (dilution of 1:50) and fluorescein isothiocyanate-labeled anti-mouse immunoglobulin (Ig)G diluted 1:60 (Dianova, Hamburg, Germany ).
For immunoblot analysis, cells were harvested and pelleted by centrifugation. The cell pellet was lysed in SDS loading buffer and boiled for 5 min. Total cell lysate was separated in an sodium dodecyl sulfate (SDS)-15% polyacrylamide gel, and proteins were transferred to nitrocellulose membrane (Schleicher & Schuell, Germany). Lassa virus Z protein was detected by chemiluminescence with polyclonal chicken anti-Z serum (dilution 1:5,000) and peroxidaselabeled anti-chicken IgY (dilution 1:2,000) (Dianova) as secondary antibody.
RT-PCR of S RNA
Virus RNA was isolated from 140 µL of serum or cell culture supernatant of Lassa virus and LCMV-infected Vero and L cells, respectively, by using the QIAamp Viral RNA kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions (elution of RNA in 50 µL of buffer). For reverse transcription of the full-length S RNA, purified RNA (3-6 µL) was incubated with 20 pmol of RT primer (CGCACCGDGGATCCTAG GC) in an 8- In a separate PCR, a 340-bp fragment of the S RNA was amplified by using Superscript One-
Step RT-PCR System (Life Technologies) and primers 36E2 (ACCGGGGATCCTAGGCATTT) and 80F2 (ATATAATGATGACTGTTGTTCTTT GTGCA) as described previously (18) .
Sequence Determination
PCR products were purified by using the QIAquick PCR purification kit (Qiagen) and were directly sequenced with the BigDye Terminator AmpliTaq kit (Applied Biosystems, Weiterstadt, Germany). Extension products were separated on an ABI 377 automated sequencer (Applied Biosystems). The 340-bp fragment was sequenced by using primers 36E2 and 80F2. The full-length S RNA amplification product of independent RTPCRs was pooled, and plus and minus strands were sequenced by the following primers 
Phylogenetic Analysis
Phylogenetic analysis was performed with the NP gene fragment for which the largest set of arenavirus sequence data exists, at position 1724-2349 of the genomic S RNA of Lassa Josiah (11) . NP gene sequences were aligned for Lassa AV and the following arenavirus strains (virus, GenBank/EMBL accession number): Tacaribe, M20304; Ippy, U80003; Mopeia AN20410, U80005; Mopeia AN21366, M33879; Mobala 3076, AF012530; Mobala 3051, U80006; Mobala 3099, U80007; Lassa LP, U80004; Lassa Nigeria, X52400; Lassa Josiah, J04324; LCMV Armstrong, M20869; LCMV WE; M22138; and LCMV MaTu-MX, Y16308. Full-length NP and GPC gene sequences were analyzed for Lassa strains Josiah, Nigeria, and AV, and for Mopeia AN21366. Phylogenetic analysis was performed by using programs of the PHYLIP 3.57c package (21) . A gap was treated as a single mutation event. Distance matrix calculation and neighborjoining (NJ) analysis were conducted with the programs DNADIST and NEIGHBOR, and maximum likelihood (ML) analysis was conducted with the DNAML program. Analyses were performed with default settings on a bootstrapped dataset (100 replicates).
Results
Origin and Isolation of the New Lassa Virus Strain
The exact geographic origin of the virus and the mode and date of transmission could not be determined. During the incubation period, which can last up to 3 weeks (22), the patient visited Ghana, Côte D'Ivoire, and Burkina Faso (Figure 1) . Therefore, the virus originated from one of these West African countries, where Lassa fever has not been reported.
The virus grew rapidly in Vero cells. Fifteen hours after inoculation, few cells were positive, and after 40 hours virtually all cells were infected in cultures injected with 0.1 mL serum as tested by immunofluorescence. In contrast to previous Lassa virus isolations in Vero cells (23) , no substantial cytopathic effects were seen. Whether this observation is due to technical variables (such as inoculation dose or culture duration) or reflects a biologic feature of the isolate is unclear.
Immunofluorescence with an NP-specific monoclonal antibody showed the speckled, cytoplasmic pattern typical of Lassa virus NP (13, 20) (Figure  2A ). Isolation of a Lassa virus was further confirmed by immunoblot analysis of strain AVinfected cells using Lassa virus Z protein-specific antibody. An 11-kDa Z protein was demonstrated ( Figure 2B ) as has recently been detected in Lassa Josiah-infected cells (24) .
RT-PCR for Amplification of Full-Length S RNA
To improve and simplify molecular analysis of new Lassa virus isolates, a protocol for reverse transcription and PCR amplification of the fulllength S RNA was established. The RT primer used for reverse transcription binds to the extreme termini of genomic and antigenomic S and L RNA ( Figure 3A ). These termini are highly conserved among all arenaviruses. Reverse transcription was performed at a baseline temperature of 50°C with short rises to 55°C and 60°C to resolve the stable RNA secondary structure of the intergenic region. A mixture of Taq and Pwo polymerases, the latter of which has 3'-5'-exonuclease (proofreading) activity, was used in PCR. This enzyme combination can amplify long templates with high fidelity and sensitivity (25) . Various primers and primer combinations tested were found suitable for efficient amplification of full-length S RNA of Lassa virus and/or LCMV: PCR1; PCR2; PCR3; PCR2 and PCR3; PCR2, PCR3, and PCR4; and PCR5 ( Figure 3B and data not shown). The PCR primers were largely identical to the RT primer but contained heterologous 5'-sequences that allow cloning of the amplification product through the restriction enzyme AscI. The 3'-end of primer PCR1 exactly corresponded to that of the RT primer, but primers PCR2 to PCR5 contained additional two or three nucleotides at their 3'-end. These nucleotides were added to reduce or prevent amplification of shorter products generated by mispriming during reverse transcription. Although the 3'-nucleotides of primers PCR2 and PCR3 did not perfectly fit onto both termini of Lassa virus S RNA, each primer alone was able to amplify the full-length fragment (data not shown). This feature, which may facilitate amplification of strains with mutations in the primer binding site, can be explained by the 3'-5'-exonuclease activity of Pwo polymerase, which degrades primers and corrects 3'-mismatches (26) . In conclusion, we developed an RT-PCR protocol allowing rapid molecular characterization of S RNA of Lassa virus and LCMV isolates. Because of the high conservation of the primer binding sites, the protocol may also be applied to other arenaviruses.
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Sequence Determination of S RNA of Lassa AV and Comparison with Lassa Josiah and Nigeria
S RNA was isolated from the patient's serum and amplified in two RT-PCRs with the primer combination PCR2, PCR3, and PCR4. Both reactions showed a major product at the 3.5-kb position ( Figure 3C ), indicating that the predominant virus population contained fulllength S RNA. Some minor species in the 1.5-to 3-kb size range may represent naturally occurring RNA, with deletion as occasionally seen in arenavirus-infected cell cultures (27) , or artifact fragments generated during RT-PCR. The PCR products were purified, pooled, and sequenced. The S RNA sequence was confirmed by sequencing the 340-bp PCR fragment produced by primers 36E2 and 80F2. The overlapping sequences were completely identical. The sequence was sent to GenBank and was assigned accession number AF246121.
Alignment of the S RNA sequence of strain Josiah with that of strains AV and Nigeria showed considerable variability among the three Research strains (Figure 4) . The highest frequency of nucleotide changes, deletions, and insertions was observed at the 3'-and 5'-noncoding regions just upstream of the GPC and NP start codons on the genomic and antigenomic strands, respectively (position 25-55 and 3303-3365). Essentially no nucleotide was conserved in these regions or in a short sequence in the intergenic region between the GPC stop codon and the beginning of the RNA stem-loop structure (position 1532-1540). In contrast to these regions, the RNA stem-loop structure (position 1545-1586) was highly conserved, with no changes in the stem and little variability in the loop. The NP and GPC coding regions differed among the three strains by approximately 20%, almost exclusively because of nucleotide exchanges (Table) . The partial NP gene sequence of strain LP differed by 25% from that of strain AV. The mutations were scattered over entire coding regions except for short conserved stretches. The most prominent feature of this variability was the high number of changes at third codon positions, which accounted for approximately 80% of all nucleotide differences (Table) . The amino acid variability was considerably lower (5%-9%) than the variability at the nucleotide level (Table) . The degree of nucleotide and amino acid sequence divergence was slightly higher in NP than in GPC. Alignment of the GPC amino acid sequences showed differences at the N-terminus and within as well as in the vicinity of the B-cell epitopes ( Figure 5) (28,29) . The putative GP1/GP2
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Research Figure 6 . Phylogenetic analysis of Old World arenaviruses, including Lassa AV. The tree was computed for an NP gene fragment by using the neighbor-joining method. Bootstrap support (in %) is indicated at the respective branch. The same topology and similar bootstrap values, except for the terminal lymphocytic choriomeningitis virus branches, were obtained by using the maximum likelihood method. Tacaribe virus belonging to the New World arenaviruses was used as outgroup to root the tree.
cleavage site (30) was completely conserved, as were potential N-linked glycosylation sites, with the exception of an additional site in Lassa AV and Nigeria at position 272. In NP, two clusters of amino acid variability (position 43-60 and 340-353) were both characterized by a high number of glycine residues at different positions in the three strains ( Figure 5 ). The mapped NP B-cell epitope (31) was conserved, and only a few changes occurred in the T-cell epitopes recently identified in NP (32) . The phylogenetic relationship of Lassa AV to known Old World arenaviruses as well as to the other Lassa strains was analyzed by using partial NP gene sequences. Strain AV segregated with all Lassa strains into a single Lassa group with 100% bootstrap support and was placed in sister relationship with strain Josiah (Figure 6 ). The latter relationship was confirmed in analyzing the full-length coding regions with 65%/61% (NJ/ ML analysis) bootstrap support for the GPC gene and 94%/97% (NJ/ML analysis) bootstrap support for the NP gene.
Conclusions
The complete S RNA sequences of three Lassa virus strains-Nigeria (16), Josiah (15) , and AV-are now known. All three full-length sequences, as well as the partial S RNA sequence of strain LP (11), differ considerably, suggesting that Lassa viruses comprise a monophyletic yet genetically diverse group. Strain AV appears to be phylogenetically most closely related to strain Josiah. Prominent features of this variability are a high number of substitutions at third-base positions, a high degree of divergence at the 3'-and 5'-noncoding regions just upstream of the NP and GPC start codons, but conservation of the intergenic stem-loop as well as the 19-nucleotide termini, which are conserved among all arenaviruses. Conservation of these termini in strain AV was not directly demonstrated in our study but was suggested by the efficient reverse transcription and amplification with primers binding to these ends. The divergence of the 3'-and 5'-noncoding regions (excluding the conserved termini) indicates either that their function does not depend on a specific primary sequence or that the functional variability of these elements has no major impact on the Lassa virus life cycle. These sequences correspond to the 5'-untranslated regions on the NP and GPC transcripts. Variability in these regions, especially in the so-called KOZAK sequence around the start codon (33) , may influence efficiency of translation initiation and, thus, protein expression and virus production. Mutations in noncoding regions may eventually explain pathogenic differences among Lassa virus strains (12), as they have in other viruses (34) (35) (36) . In contrast to the 3'-and 5'-noncoding regions, the RNA stem-loop structure was highly conserved, suggesting that this element does not allow modification without seriously affecting Lassa virus replication. Of the other arenaviruses, only Mopeia virus has stem-loop sequences in common with Lassa virus (37) , which may be one reason that both viruses can form stable reassortants (38) . The diverse geographic origins of three of the four prototype strains (LP and Nigeria are both of Nigerian origin) and the relatedness of isolates circulating within an area Research (13) The high degree of variability poses problems for the design of diagnostic PCR and sequencing primers. Most of our sequencing primers that were designed on the basis of sequences of strain Josiah and Nigeria failed to anneal to the new strain as a result of several mutations in their binding sites. In addition, the binding site of primer 80F2 (18) , which had been designed for diagnostics on the basis of nine Lassa sequences, contained three mutations. As they affected only the 5' half of the primer, performance of the PCR was not seriously reduced, confirming its usefulness for diagnostic purposes. The fulllength S RNA RT-PCR may be an alternative for diagnostics because of its highly conserved primer binding sites, although its sensitivity may be somewhat lower.
Phylogenetic analysis showed minor differences in the tree topology of the Old World arenaviruses in comparison to previous analysis (11) . In our analysis, Mobala and Mopeia viruses were placed in close relationship, while the previous study indicated that Mobala is most closely related with Lassa virus. However, in both studies, bootstrap support was low and the tree topology depended on the inclusion of changes at the third codon position (11) . Placement of Lassa Nigeria, Josiah, and LP differed in both studies in a similar manner. Analysis of additional sequences may be required to elucidate the exact phylogenetic relationship among Mopeia, Mobala, and Lassa viruses, as well as between Lassa virus strains Nigeria, Josiah, and LP.
Development of a vaccine against Lassa virus is a main goal of research (39) . Protective immunity is achieved in animals by vaccination with Lassa NP or GPC-expressing vaccinia virus and seems to be mediated by the T-cell response (40) (41) (42) . However, whether a recombinant vaccine based on a single Lassa protein of a specific strain cross-protects against heterologous Lassa strains has not yet been studied. Recently, several epitopes recognized by Lassa NP-specific CD4+ T-cell clones of one person were mapped (32) . Most of them are conserved in at least two of three Lassa strains (Josiah, Nigeria, and AV). The relatively large number of T-cell epitopes recognized, as well as their partial conservation, suggests a level of T-cell crossreactivity that might be sufficient for crossprotection against heterologous strains after immunization with NP-based vaccines. This view is supported by experiments with Lassa GPCbased vaccines, which indicate CD4+ T-cellmediated cross-protection even against LCMV (43) . Use of the new Lassa virus strain as heterologous challenge virus after immunization with recombinant vaccines, as well as use of its proteins in in-vitro assays to study T-cell crossreactivity, may enhance our understanding of Lassa virus-specific cross-protective immunity.
